期刊
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
卷 26, 期 10, 页码 1900-1905出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.bbmt.2020.06.027
关键词
Severe aplastic anemia; Alemtuzumab; FCC conditioning; Children
Various reduced-intensity conditioning regimens are in use for allogeneic hematopoietic cell transplant (HSCT) in patients with idiopathic severe aplastic anemia (SAA). We describe the use of fludarabine, Campath, and low-dose cyclophosphamide (FCClow) conditioning in 15 children undergoing related or unrelated donor transplants. Total body irradiation (TBI) of 2 Gy was added for unrelated donor HSCT. At a median follow-up of 2.3 years, the failure-free survival was 100%, with low rates of infection and toxicity. There was no occurrence of grade III to IV acute graft-versus-host disease (GVHD). All patients had full donor myeloid chimerism post-HSCT, even with mixed chimerism in the T cell lineage. The absence of chronic GVHD and long-term stable mixed donor T cell chimerism confirms immune tolerance following FCClow (+/-TBI) conditioned transplantation in children with SAA. Crown Copyright (c) 2020 Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据